<DOC>
	<DOCNO>NCT01969942</DOCNO>
	<brief_summary>The purpose study examine toxicity use allogeneic stem cell transplantation treatment subject relapse refractory Ewing Sarcoma ( ES ) . Donors consist either Human Leukocyte Antigen identical ( HLA ) 9/10 ( A , B , C , DR , DQ [ A , B , C , Class I marker HLA DR DQ Class II marker Matching Transplant Donors match recipient ] ) match related unrelated donor . Specifically , examine : - The toxicity allogeneic stem cell transplant ( SCT ) patient population , related incidence grade 3-4 acute Graft Verse Host Disease ( GVHD ) . - The incidence transplant relate mortality 100 day .</brief_summary>
	<brief_title>A Phase I Study Examine Toxicity Allogeneic Stem Cell Transplantation Relapsed Therapy Refractory Ewing Sarcoma</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<mesh_term>Melphalan</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Patients age 030 year relapse therapy refractory Ewings sarcoma , exclude patient brain metastasis . Patients receive prior autologous stem cell transplant eligible . Related unrelated marrow peripheral blood stem donor must 9/10 10/10 ( HLA A , B , C , DR , DQ ) match recipient . Organ dysfunction : Patients follow level organ system dysfunction eligible : Cardiac : Ejection Fraction le 50 percent Renal : Est . Creatinine Clearance less 50 Hepatic : Bilirubin great 3.0 Pulmonary : Diffusing Capacity Carbon Monoxide ( DLCO ) less 70 percent , patient cooperate pulmonary function testing , O2 saturation le 95 percent room air . Performance status : Lansky performance le 70 ; Eastern Cooperative Oncology Group ( ECOG ) status great equal 2 Patients isolated recurrence tumor ( site primary tumor ) great 1 year complete therapy exclude patient could cure local therapy alone . As part standard care pretransplant evaluation subject test exposure viral agent hepatitis B , C , HTLV1/2 HIV . Subjects test positive HI may reject candidate transplantation , base clinical judgement stem cell transplant physician .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Ewings sarcoma</keyword>
</DOC>